Shots:
- Tempus AI has received the US FDA 510(k) clearance for its updated Tempus Pixel, an AI-powered cardiac imaging platform, with the ability to generate T1 & T2 inline maps for enhanced cardiac MRI analysis
- Tempus Pixel delivers advanced viewing & automated reporting of cardiac MR images, improving efficiency and accuracy in flow visualization, functional analysis, & tissue characterization to support faster, more informed clinical decisions
- The newly cleared functionality enables direct creation of T1 & T2 maps from raw MRI data, providing precise tissue characterization & generating detailed DICOM maps to detect fibrosis, inflammation, or edema
Ref: Tempus | Image: Tempus | Press Release
Related News:- Imagene Partners with Tempus AI to Develop AI-Powered Diagnostics for NSCLC
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
